ZC3HAV1L

Zinc finger CCCH-type antiviral protein 1-like · Q96H79 · ZC3HAV1L on Sugi Atlas →

0 patent compounds predicted against ZC3HAV1L, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ZC3HAV1L by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes PHASE4COMPLETED
Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy PHASE2NOT_YET_RECRUITING
Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL PHASE2NOT_YET_RECRUITING
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS) PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
CCR5-modified CD4+ T Cells for HIV Infection PHASE1/PHASE2COMPLETED
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children PHASE1/PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients PHASE1/PHASE2COMPLETED
Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV PHASE1COMPLETED
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein PHASE1COMPLETED
Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) EARLY_PHASE1UNKNOWN
Serum Levels of Some Trace Elements in Hepatocellular Carcinoma Patients nanUNKNOWN
Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections nanNOT_YET_RECRUITING
Chi-GVM Regimen for the Treatment of R/R PTCL nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches nanUNKNOWN
ADAR1 Expression Level in Rectal Cancer nanRECRUITING
Immunomodulatory and Preventive Effects of Olive Leaf Tea Against COVID-19 nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Immune Cell Response to Stimuli nanRECRUITING
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates nanCOMPLETED
Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic Profile nanUNKNOWN
Effect of Periodontal Treatment on Inflammasome Proteins in Periodontal Diseases nanUNKNOWN
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Zn Supplementation in HIV Immunological Non Responders nanRECRUITING
Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction. nanUNKNOWN
German Centre for Infection Research HIV Translational Platform nanRECRUITING
Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV. nanUNKNOWN
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a ZC3HAV1L binder may also engage these)

ProteinNameSimilarity
Q8BFR1 0.995 Q8BFR1 →
Q5RF77 0.981 Q5RF77 →
Q96EP1 0.976 Q96EP1 →
D2HNY3 0.973 D2HNY3 →
Q5F479 0.972 Q5F479 →
Q9Y5B0 0.972 Q9Y5B0 →
Q8JZL1 0.972 Q8JZL1 →
TERF2 Telomeric repeat-binding factor 2 0.972 landscape →
Q7T0L4 0.972 Q7T0L4 →
Q9UGR2 0.972 Q9UGR2 →
Q924T7 0.972 Q924T7 →
Q62925 0.972 Q62925 →
Q9Y6J9 0.972 Q9Y6J9 →
Q9BRS8 0.971 Q9BRS8 →
Q96NW4 0.971 Q96NW4 →
Q810L3 0.971 Q810L3 →
Q8R2K4 0.971 Q8R2K4 →
Q5REW9 0.971 Q5REW9 →
Q5SUE8 0.971 Q5SUE8 →
Q8K245 0.971 Q8K245 →
Q7TSG2 0.970 Q7TSG2 →
Q400G9 0.970 Q400G9 →
P53349 0.970 P53349 →
Q6ZW76 0.970 Q6ZW76 →
RORC Nuclear receptor ROR-gamma 0.970 landscape →
Q8C0R7 0.970 Q8C0R7 →
Q69ZT1 0.969 Q69ZT1 →
Q6ZRF8 0.969 Q6ZRF8 →
Q8VDP4 0.969 Q8VDP4 →
Q6P256 0.969 Q6P256 →